Bonus BioGroup Ltd.
BBIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $3 | $4 |
| Gross Profit | $0 | $0 | -$3 | -$4 |
| % Margin | – | – | – | – |
| R&D Expenses | $18 | $19 | $21 | $21 |
| G&A Expenses | $10 | $11 | $5 | $31 |
| SG&A Expenses | $10 | $11 | $5 | $31 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $7 | $9 |
| Operating Expenses | $28 | $30 | $34 | $61 |
| Operating Income | -$28 | -$30 | -$37 | -$65 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $1 | -$2 | -$25 |
| Pre-Tax Income | -$28 | -$29 | -$39 | -$90 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$28 | -$29 | -$39 | -$90 |
| % Margin | – | – | – | – |
| EPS | -0.024 | -0.024 | -0.033 | -0.078 |
| % Growth | 2.5% | 26.3% | 57.6% | – |
| EPS Diluted | -0.024 | -0.024 | -0.033 | -0.078 |
| Weighted Avg Shares Out | 1,168 | 1,168 | 1,168 | 1,154 |
| Weighted Avg Shares Out Dil | 1,168 | 1,168 | 1,168 | 1,154 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $7 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $3 | $1 |
| EBITDA | -$26 | -$28 | -$35 | -$88 |
| % Margin | – | – | – | – |